Avrion Therapeutics AG
PrivateLast Round
Seed
Jun 1, 2021
Total Funding Raised
$2.42M
Company Overview
Avrion Therapeutics AG is a biotechnology company that develops precision gene therapy solutions for genetically defined neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avrion Therapeutics AG Comparables
Compare Avrion Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celosia Therapeutics | 88% | |
| SineuGene Therapeutics | 85% | |
| Capsida Biotherapeutics | 81% | |
Avrion Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2021 | ||||
| Grant | Jun 1, 2021 |
Avrion Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2021
$1.1M round with Gaël Hédou participating.
Avrion Therapeutics AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avrion Therapeutics AG's valuation, stock price, and market status.